Literature DB >> 20493973

Approaches to deorphanization of human and microbial cytochrome P450 enzymes.

F Peter Guengerich1, Zhongmei Tang, Qian Cheng, S Giovanna Salamanca-Pinzón.   

Abstract

One of the general problems in biology today is that we are characterizing genomic sequences much faster than identifying the functions of the gene products, and the same problem exists with cytochromes P450 (P450). One fourth of the human P450s are not well-characterized and therefore considered "orphans." A number of approaches to deorphanization are discussed generally. Several liquid chromatography-mass spectrometry approaches have been applied to some of the human and Streptomyces coelicolor P450s. One current limitation is that too many fatty acid oxidations have been identified and we are probably missing more relevant substrates, possibly due to limits of sensitivity.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493973      PMCID: PMC2939962          DOI: 10.1016/j.bbapap.2010.05.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  48 in total

1.  Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1.

Authors:  Maria Karlgren; Maria Backlund; Inger Johansson; Mikael Oscarson; Magnus Ingelman-Sundberg
Journal:  Biochem Biophys Res Commun       Date:  2004-03-12       Impact factor: 3.575

Review 2.  Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.

Authors:  J R Idle; R L Smith
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

3.  Drug metabolism by Escherichia coli expressing human cytochromes P450.

Authors:  A Parikh; E M Gillam; F P Guengerich
Journal:  Nat Biotechnol       Date:  1997-08       Impact factor: 54.908

4.  Heterologous expression, purification, and properties of human cytochrome P450 27C1.

Authors:  Zhong-Liu Wu; Cheryl J Bartleson; Amy-Joan L Ham; F Peter Guengerich
Journal:  Arch Biochem Biophys       Date:  2005-11-28       Impact factor: 4.013

5.  A soluble cytochrome P-450 functional in methylene hydroxylation.

Authors:  M Katagiri; B N Ganguli; I C Gunsalus
Journal:  J Biol Chem       Date:  1968-06-25       Impact factor: 5.157

6.  Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.

Authors:  Maria Karlgren; Alvin Gomez; Katarina Stark; Jenny Svärd; Cristina Rodriguez-Antona; Ernst Oliw; Maria Luisa Bernal; Santiago Ramón y Cajal; Inger Johansson; Magnus Ingelman-Sundberg
Journal:  Biochem Biophys Res Commun       Date:  2006-01-11       Impact factor: 3.575

7.  The enolase superfamily: a general strategy for enzyme-catalyzed abstraction of the alpha-protons of carboxylic acids.

Authors:  P C Babbitt; M S Hasson; J E Wedekind; D R Palmer; W C Barrett; G H Reed; I Rayment; D Ringe; G L Kenyon; J A Gerlt
Journal:  Biochemistry       Date:  1996-12-24       Impact factor: 3.162

8.  Phospholipase D activity of cytochrome P450 in human liver endoplasmic reticulum.

Authors:  C H Yun; T Ahn; F P Guengerich; H Yamazaki; T Shimada
Journal:  Arch Biochem Biophys       Date:  1999-07-01       Impact factor: 4.013

Review 9.  Novel extrahepatic cytochrome P450s.

Authors:  Maria Karlgren; Shin-ichi Miura; Magnus Ingelman-Sundberg
Journal:  Toxicol Appl Pharmacol       Date:  2005-09-01       Impact factor: 4.219

10.  Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.

Authors:  R R Shah; N S Oates; J R Idle; R L Smith; J D Lockhart
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30
View more
  11 in total

Review 1.  Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology.

Authors:  F Peter Guengerich; Qian Cheng
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

2.  Origins of P450 diversity.

Authors:  Hideki Sezutsu; Gaëlle Le Goff; René Feyereisen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

3.  A Role for the Orphan Human Cytochrome P450 2S1 in Polyunsaturated Fatty Acid ω-1 Hydroxylation Using an Untargeted Metabolomic Approach.

Authors:  Mostafa I Fekry; Yi Xiao; Jeannette Zinggeler Berg; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2019-09-11       Impact factor: 3.922

Review 4.  Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states.

Authors:  Edward J Kelly; Mariko Nakano; Priyanka Rohatgi; Vladimir Yarov-Yarovoy; Allan E Rettie
Journal:  Mol Interv       Date:  2011-04

5.  Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase.

Authors:  Yi Xiao; Raku Shinkyo; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2011-03-23       Impact factor: 3.922

6.  Identification of endogenous substrates of orphan cytochrome P450 enzymes through the use of untargeted metabolomics approaches.

Authors:  Qian Cheng; F Peter Guengerich
Journal:  Methods Mol Biol       Date:  2013

7.  Bioactivation of Aromatic Amines by Human CYP2W1, An Orphan Cytochrome P450 Enzyme.

Authors:  Chang-Yong Eun; Songhee Han; Young-Ran Lim; Hyoung-Goo Park; Jung-Soo Han; Kyoung Sang Cho; Young-Jin Chun; Donghak Kim
Journal:  Toxicol Res       Date:  2010-09

8.  A transcriptomic approach to elucidate the physiological significance of human cytochrome P450 2S1 in bronchial epithelial cells.

Authors:  Thushara W Madanayake; Ingrid E Lindquist; Nicholas P Devitt; Joann Mudge; Aaron M Rowland
Journal:  BMC Genomics       Date:  2013-11-26       Impact factor: 3.969

Review 9.  Metabolomic strategies for the identification of new enzyme functions and metabolic pathways.

Authors:  Gareth A Prosser; Gerald Larrouy-Maumus; Luiz Pedro S de Carvalho
Journal:  EMBO Rep       Date:  2014-05-14       Impact factor: 8.807

10.  Corticosteroid Biosynthesis Revisited: No Direct Hydroxylation of Pregnenolone by Steroid 21-Hydroxylase.

Authors:  Steffen Loke; Anna Stoll; David Machalz; Francesco Botrè; Gerhard Wolber; Matthias Bureik; Maria Kristina Parr
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-03       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.